Clinical trial EZH-202
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
| Cancers | |
|---|---|
| Organ | Soft tissue |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Epizyme |
| EudraCT Identifier | 2015-002469-41 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02601950 |
| Inclusion criteria | after standard therapy |
| Last update |